These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy. Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS. Clin Cancer Res; 2005 Aug 15; 11(16):5950-5. PubMed ID: 16115938 [Abstract] [Full Text] [Related]
25. Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Forest V, Peoc'h M, Campos L, Guyotat D, Vergnon JM. Cryobiology; 2005 Feb 15; 50(1):29-37. PubMed ID: 15710367 [Abstract] [Full Text] [Related]
26. Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model. Wacheck V, Heere-Ress E, Halaschek-Wiener J, Lucas T, Meyer H, Eichler HG, Jansen B. J Mol Med (Berl); 2001 Oct 15; 79(10):587-93. PubMed ID: 11692156 [Abstract] [Full Text] [Related]
29. Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro. Benimetskaya L, Ayyanar K, Kornblum N, Castanotto D, Rossi J, Wu S, Lai J, Brown BD, Popova N, Miller P, McMicken H, Chen Y, Stein CA. Clin Cancer Res; 2006 Aug 15; 12(16):4940-8. PubMed ID: 16914583 [Abstract] [Full Text] [Related]
30. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications. Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M. Ann N Y Acad Sci; 2004 Dec 15; 1028():90-103. PubMed ID: 15650235 [Abstract] [Full Text] [Related]
31. Antitumor activity of a novel bis-aziridinylnaphthoquinone (AZ4) mediating cell cycle arrest and apoptosis in non-small cell lung cancer cell line NCI-H460. Shyu KG, Huang ST, Kuo HS, Cheng WP, Lin YL. Acta Pharmacol Sin; 2007 Apr 15; 28(4):559-66. PubMed ID: 17376296 [Abstract] [Full Text] [Related]
32. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model. Bartholomeusz C, Itamochi H, Yuan LX, Esteva FJ, Wood CG, Terakawa N, Hung MC, Ueno NT. Cancer Res; 2005 Sep 15; 65(18):8406-13. PubMed ID: 16166319 [Abstract] [Full Text] [Related]
33. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. Mol Carcinog; 2009 Jan 15; 48(1):24-37. PubMed ID: 18459128 [Abstract] [Full Text] [Related]
34. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models. Mewani RR, Tang W, Rahman A, Dritschilo A, Ahmad I, Kasid UN, Gokhale PC. Int J Oncol; 2004 May 15; 24(5):1181-8. PubMed ID: 15067340 [Abstract] [Full Text] [Related]
40. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Zou Y, Fu H, Ghosh S, Farquhar D, Klostergaard J. Clin Cancer Res; 2004 Nov 01; 10(21):7382-91. PubMed ID: 15534115 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]